Cargando…

Successful treatment of refractory tumor necrosis factor inhibitor-induced palmoplantar pustulosis with tofacitinib: Report of case

Detalles Bibliográficos
Autores principales:	Wang, Yixin Ally, Rosenbach, Misha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6992880/ https://www.ncbi.nlm.nih.gov/pubmed/32016154 http://dx.doi.org/10.1016/j.jdcr.2019.12.006

Ejemplares similares

Refractory Palmoplantar Pustulosis Successfully Treated with JAK Inhibitor Tofacitinib: A Case Series
por: Xu, Qingqing, et al.
Publicado: (2023)

Secukinumab-Induced Alopecia Areata Successfully Treated with Tofacitinib in a Patient with Palmoplantar Pustulosis
por: Zhang, Chen, et al.
Publicado: (2023)

Amicrobial pustulosis of the folds and palmoplantar pustulosis simultaneously induced by different tumor necrosis factor-α inhibitors: Demonstration of a shared pathophysiology
por: Zirwas, Matthew, et al.
Publicado: (2017)

Palmoplantar pustulosis–like eruption following tofacitinib therapy for juvenile idiopathic arthritis
por: Shibata, Tomoyuki, et al.
Publicado: (2019)

Successful Treatment of Recalcitrant Palmoplantar Pustulosis with Guselkumab
por: Jung, Jang Hwan, et al.
Publicado: (2023)

Palmoplantar Pustulosis: A Case Report
por: Dulski, Anne, et al.
Publicado: (2020)

Palmoplantar pustulosis secondary to anti-tumor necrosis factor therapy in a patient with ankylosing spondylitis
por: Bae, Jung Min, et al.
Publicado: (2020)

A Patient with Adalimumab-Induced Refractory Paradoxical Palmoplantar Pustulosis Was Successfully Treated by Ixekizumab: A Case Report
por: Shao, Xin-Yi, et al.
Publicado: (2023)

Recent advances in palmoplantar pustulosis
por: Brunasso, Alexandra Maria Giovanna, et al.
Publicado: (2021)

Successful treatment of adalimumab-resistant palmoplantar pustulosis with secukinumab: a case report
por: Li, Qing-Yang, et al.
Publicado: (2020)

Palmoplantar pustulosis and IgA nephropathy
por: Shimamura, Yoshinosuke, et al.
Publicado: (2018)

Palmoplantar Pustulosis associated with Membranous Glomerulonephritis
por: Thakur, Vishal, et al.
Publicado: (2021)

Association of Clinical and Demographic Factors With the Severity of Palmoplantar Pustulosis
por: Benzian-Olsson, Natashia, et al.
Publicado: (2020)

Apremilast monotherapy for palmoplantar pustulosis: Report of three cases
por: Marovt, Maruška, et al.
Publicado: (2021)

SAPHO Syndrome with Palmoplantar Pustulosis as the First Manifestation Successfully Treated with Adalimumab
por: Yang, Qingyun, et al.
Publicado: (2022)

A Case of Relapsing Polychondritis with Palmoplantar Pustulosis
por: Kwon, Won Joo, et al.
Publicado: (2016)

Skin-directed radiation therapy for palmoplantar pustulosis
por: King, Brian J., et al.
Publicado: (2019)

Apremilast in Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review and Meta-analysis
por: Spencer, Riley K., et al.
Publicado: (2023)

Improvement of lymphangioleiomyomatosis following successful tofacitinib treatment for refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome
por: Liu, Shuang, et al.
Publicado: (2019)

Palmoplantar Pustulosis: A Systematic Review of Risk Factors and Therapies
por: Heidemeyer, Kristine, et al.
Publicado: (2023)

The Efficacy of Biologic Therapy for the Management of Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review
por: Sanchez, Isabelle M., et al.
Publicado: (2017)

Combination biologic therapy for the treatment of severe palmoplantar pustulosis
por: Torre, Kristin M., et al.
Publicado: (2017)

Palmoplantar Pustulosis: Recent Advances in Etiopathogenesis and Emerging Treatments
por: Misiak-Galazka, Magdalena, et al.
Publicado: (2020)

Clinical characteristics and associations of palmoplantar pustulosis: an observational study()()
por: Oktem, Ayse, et al.
Publicado: (2020)

Guselkumab for the Treatment of Palmoplantar Pustulosis: A Japanese Perspective
por: Yamamoto, Toshiyuki
Publicado: (2021)

Relapse of Palmoplantar Pustulosis Following COVID-19 Vaccination
por: Katsuie, Shiho, et al.
Publicado: (2022)

Successful Treatment of a Patient with Pyoderma Gangrenosum, Plaque Psoriasis and Palmoplantar Pustulosis with Adalimumab
por: Chu, Yuqi, et al.
Publicado: (2022)

Principal Component Analysis to Differentiate Patients with Palmoplantar Pustulosis from Those with Palmoplantar Pustular Psoriasis
por: Kim, Tae Hyung, et al.
Publicado: (2022)

Tofacitinib for the treatment of tumor necrosis factor-α inhibitor refractory esophageal Crohn’s disease: a case report
por: Nathoo, Sunina, et al.
Publicado: (2016)

Palmoplantar Pustulosis Induced by both Adalimumab and Golimumab for Treatment of Ankylosing Spondylitis
por: Seol, Jung Eun, et al.
Publicado: (2016)

Palmoplantar Pustulosis-like Eruption Induced by Baricitinib for Treatment of Rheumatoid Arthritis
por: Koumaki, Dimitra, et al.
Publicado: (2019)

Successful Treatment of Rituximab-Associated Palmoplantar Pustulosis With Apremilast in a Patient With Seropositive Rheumatoid Arthritis
por: Haller, Christoph, et al.
Publicado: (2021)

Rapid remission of refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome in response to the Janus kinase inhibitor tofacitinib: A case report
por: Li, Ben, et al.
Publicado: (2020)

Vesicular LL-37 Contributes to Inflammation of the Lesional Skin of Palmoplantar Pustulosis
por: Murakami, Masamoto, et al.
Publicado: (2014)

Improvement of palmoplantar pustulosis after excision of polyacrylamide injected into the nasal region
por: Kashiyama, Kazuya, et al.
Publicado: (2021)

Design and implementation of an adaptive confirmatory trial in Japanese patients with palmoplantar pustulosis
por: Zheng, Richuan, et al.
Publicado: (2022)

Adalimumab Biosimilar-Induced Severe Paradoxical Palmoplantar Pustulosis in a Patient with Psoriasis and Psoriatic Arthritis Successfully Treated with Ixekizumab
por: Gkalpakiotis, Spyridon, et al.
Publicado: (2022)

Case report: successful treatment of refractory SAPHO syndrome with the JAK inhibitor tofacitinib
por: Yang, Qiao, et al.
Publicado: (2018)

CNVs Associated with Different Clinical Phenotypes of Psoriasis and Anti-TNF-Induced Palmoplantar Pustulosis
por: Reolid, Alejandra, et al.
Publicado: (2022)

Efficacy and Safety of Oral Alitretinoin in Hand Eczema and Palmoplantar Pustulosis in Korean Patients
por: Lee, Ji Su, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2klpe0fbamaf2c2n29jir6r7d2